Merck & Co lifts outlook as Keytruda growth offsets acquisition hit - The Pharma Letter
Merck & Co lifts outlook as Keytruda growth offsets acquisition hit The Pharma Letter
Merck & Co lifts outlook as Keytruda growth offsets acquisition hit The Pharma Letter
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.